Black Diamond Therapeutics, Inc. (BDTX) › Capital ExpendituresBlack Diamond Therapeutics, Inc. (BDTX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $76.0K2019: $21.0K2020: $142.0K2021: $2.71M2022: $192.0K2023: $33.0K2024: $0$02018Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0-100.0%2023$33.0K-82.8%2022$192.0K-92.9%2021$2.71M+1808.5%2020$142.0K+576.2%2019$21.0K-72.4%2018$76.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share